{Reference Type}: Journal Article
{Title}: New government drug repurposing programs: Opportunities and uncertainties.
{Author}: Liddicoat J;Hamidzadeh A;Liddell K;Schito M;Simon D;Aboy M;Minssen T;
{Journal}: Sci Transl Med
{Volume}: 16
{Issue}: 753
{Year}: 2024 Jun 26
{Factor}: 19.319
{DOI}: 10.1126/scitranslmed.adl0998
{Abstract}: Drug repurposing can be cheaper and faster than developing new compounds. Yet, it remains underused, partially because of regulatory and intellectual property challenges. Policy-makers in the United States and Europe have created seven drug development programs that aim to overcome these challenges using a variety of different strategies.